Identification of a polyclonal B-cell activator in Plasmodium falciparum

被引:111
作者
Donati, D
Zhang, LP
Chen, Q
Chêne, A
Flick, K
Nyström, M
Wahlgren, M
Bejarano, MT
机构
[1] Huddinge Univ Hosp, Karolinska Inst, Dept Med, CIM, S-14186 Huddinge, Sweden
[2] Karolinska Inst, Microbiol & Tumorbiol Ctr, Stockholm, Sweden
[3] Swedish Inst Infect Dis Control, Stockholm, Sweden
关键词
D O I
10.1128/IAI.72.9.5412-5418.2004
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Polyclonal B-cell activation and hypergammaglobulinemia are prominent features of human malaria. We report here that Plasmodium falciparum-infected erythrocytes directly adhere to and activate peripheral blood B cells from nonimmune donors. The infected erythrocytes employ the cysteine-rich interdomain region 1alpha (CIDR1alpha) of P. falciparum erythrocyte membrane protein 1 (PfEMP1) to interact with the B cells. Stimulation with recombinant CIDR1alpha induces proliferation, an increase in B-cell size, expression of activation molecules, and secretion of immunoglobulins (immunoglobulin M) and cytokines (tumor necrosis factor alpha and interleukin-6). Furthermore,, CIDR1alpha binds to Fab and Fc fragments of human immunoglobulins and to immunoglobulins purified from the sera of different animal species. This binding pattern is similar to that of the polyclonal B-cell activator Staphylococcus aureus protein A. Our findings shed light on the understanding of the molecular basis of polyclonal B-cell activation during malaria infections. The results suggest that the var gene family encoding PfEMP1 has evolved not only to mediate the sequestration of infected erythrocytes but also to manipulate the immune system to enhance the survival of the parasite.
引用
收藏
页码:5412 / 5418
页数:7
相关论文
共 31 条
[1]   ALTERATIONS IN SERUM PROTEINS AND 19S ANTIBODY PRODUCTION DURING COURSE OF INDUCED MALARIAL INFECTIONS IN MAN [J].
ABELE, DC ;
TOBIE, JE ;
HILL, GJ ;
CONTACOS, PG ;
EVANS, CB .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1965, 14 (02) :191-&
[2]  
ADU D, 1982, CLIN EXP IMMUNOL, V49, P310
[3]   CD4 T cell responses to a variant antigen of the malaria parasite Plasmodium falciparum, erythrocyte membrane protein-1, in individuals living in malaria-endemic areas [J].
Allsopp, CEM ;
Sanni, LA ;
Reubsaet, L ;
Ndungu, F ;
Newbold, C ;
Mwangi, T ;
Marsh, K ;
Langhorne, J .
JOURNAL OF INFECTIOUS DISEASES, 2002, 185 (06) :812-819
[4]   Identification of Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) as the rosetting ligand of the malaria parasite P-falciparum [J].
Chen, Q ;
Barragan, A ;
Fernandez, V ;
Sundstrom, A ;
Schlichtherle, M ;
Sahlen, A ;
Carlson, J ;
Datta, S ;
Wahlgren, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (01) :15-23
[5]   The semiconserved head structure of Plasmodium falciparum erythrocyte membrane protein 1 mediates binding to multiple independent host receptors [J].
Chen, QJ ;
Heddini, A ;
Barragan, A ;
Fernandez, V ;
Pearce, SFA ;
Wahlgren, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (01) :1-9
[6]   MALARIA ANTIBODY CONTENT OF GAMMA2-7S GLOBULIN IN TROPICAL POPULATIONS [J].
CURTAIN, CC ;
GORMAN, JG ;
KIDSON, C ;
CHAMPNESS, DL .
NATURE, 1964, 203 (495) :1366-&
[7]   CAN MALARIA-ASSOCIATED POLYCLONAL LYMPHOCYTE-B ACTIVATION INTERFERE WITH THE DEVELOPMENT OF ANTI-SPOROZOITE SPECIFIC IMMUNITY [J].
DANIELRIBEIRO, C ;
DEOLIVEIRAFERREIRA, J ;
BANIC, DM ;
GALVAOCASTRO, B .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1989, 83 (03) :289-292
[8]  
DAVIES AH, 1956, BRIT MED J, V22, P686
[9]   Characterization of human T- and B-cell epitopes in the C terminus of Plasmodium falciparum merozoite surface protein 1: Evidence for poor T-cell recognition of polypeptides with numerous disulfide bonds [J].
Egan, A ;
Waterfall, M ;
Pinder, M ;
Holder, A ;
Riley, E .
INFECTION AND IMMUNITY, 1997, 65 (08) :3024-3031
[10]  
ENDRESEN C, 1979, ACTA PATH MICRO IM C, V87, P185